ACAD
ACADIA Pharmaceuticals Inc.

Market cap $3.8404B
Enterprise value $3.4738B
Employees 425
Revenue $93.3M
EBITDA -$299M
Income -$299M
EPS -2.46
P/E N/A
Forward P/E -17.87
EV/EBITDA -11.61
PEG -0.33
Earnings date 2018-02-26
Volume 621k / 1.61M
Relative vol. 0.39 ×
Profit margin 0.00%
Oper. margin -323.45%
Gross margin 13.85%
Sales Q/Q 197.43%
Sales Y/Y 14,131.15%
Est. EPS Q/Q N/A
Beta 4.08
Mean Recomm. 2.10
IPO year 2004
Country United States
RSI 46.56
Range $30.81 – $31.55
52 weeks $25.06 – $41.20
SMA 50 $29 -5.35%
SMA 200 $32 +3.60%
1 year target $49 +57.66%

Intraday

5 days

1 month

3 months

6 months

1 year

5 years

10 years

All time

Messenger